Approval for iol models sn6at3, sn6at4 and sn6at5. thedevice, as modified, will be marketed under the trade name acrysof iq toric intraocular lenses and is indicated for primary implantation in the capsular bag of the eye for visual correction ofaphakia and pre-existing corneal astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia, who desire improved uncorrected distance vision, reduction of residual refractive cylinder and increased spectacle independence for distance vision.